In search for treatment options with less adverse effects, we previously reported that inhibition of FGF23 signaling by the use of an FGF23 antagonist successfully rescues renal anemia and attenuates iron deficiency and inflammation in a CKD mouse model (18). The gene discussed is FGF23; the disease is chronic kidney disease.